Franklin M. Berger

Board Member at Five Prime Therapeutics, Inc.

Are you Franklin M. Berger? Claim your profile
 
  • IDENTIFY executive and board member connections in Franklin M. Berger's network.
  • FOLLOW changes in Franklin M. Berger's employment.
  • CONNECT with Franklin M. Berger through your network of contacts.

Franklin M. Berger's Executive Work History


Current
Past
To view Franklin M. Berger's complete executive work history,
Age
67
 
 

Franklin M. Berger's Biography


Mr. Berger started his consulting practice, FMB Research, in 2003 after leaving J. P. Morgan Securities, Inc. as head of biotechnology equity research. His clients were exclusively biotechnology industry participants including major biopharmaceutical firms, mid-capitalization biotechnology companies, specialist asset managers and venture capital companies. Assignments included business development, strategic advisory/financings, partnering and royalty acquisitions. Past mandates included PDL BioPharma, Inc., Intra-Cellular Therapeutics, Inc., Serono, Merck KGaA, Threshold Pharmaceuticals, Valeant, Kleiner Perkins Caufield & Byers (incomplete ...

(Read More)

Source: Kezar Life Sciences, Inc. on 03/31/2017

 

By accessing BoardEdge, you can view bios, network, connections and references of industry leading executives like Franklin M. Berger. More specifically, you'll be able to:

  • IDENTIFY executive and board member connections in Franklin M. Berger's network.
  • FOLLOW changes in Franklin M. Berger's employment.
  • CONNECT with Franklin M. Berger through your network of contacts.
 

Access over 170,000 executive and board member profiles.

/bio

Example: Franklin M. Berger

Franklin M. Berger's Connections (176)


Former Chief Financial Officer, LifeMap Solutions Inc., BioTime, Inc.
Senior Vice President and Chief Financial Officer, Five Prime Therapeutics, Inc.
Executive Chairman of the Board, Five Prime Therapeutics, Inc.
Former Executive Vice President and Chief Operating Officer, Asterias Biotherapeutics, Inc.
Chief Medical Officer and Executive Vice President, Research and Development, Seattle Genetics, Inc.
Dir., President and Chief Executive Officer, Five Prime Therapeutics, Inc.